Belpointe Asset Management Q2 2026 Portfolio Activity: Significant ETF Purchases Observed

As reported by InsiderSet on belpointe-asset-management-llc, Belpointe Asset Management Llc's portfolio saw changes as of June 30, 2026. The total disclosed value for the period is $2.7 billion (approximately).

Prominent Purchases This Quarter

Belpointe Asset Management demonstrated significant buying activity during Q2 2026, focusing on exchange-traded funds (ETFs). Notably large purchases were observed in:

• VUG (Vanguard Information Technology ETF), which experienced a substantial 482.5% increase in shares, adding $33 million worth of holdings.
• VO (Vanguard Total Stock Market ETF), showing a significant 306.66% jump in share count for this quarter, representing an increase of $15 million.
• CGGO (Capital Group Global Equity ETF), which saw a massive 651.69% rise in shares this quarter, adding approximately $10 million to the portfolio.
• ILF (iShares Core S&P Small-Cap Index Fund), showing a moderate increase of 2.37% in shares, though its allocation remains small at just $0.69 million.
• VGT (iShares Core S&P Small-Cap Technology Growth ETF), which saw a significant 631.88% increase in shares this quarter, adding $7.9 million.

Their buying focus appears to be on growth-oriented and broad market exposure ETFs during the second quarter of 2026.

Significant Sales Observed

In contrast to their purchases, Belpointe Asset Management also reported notable selling activity in Q2. Key exits included:

• BIL (SPDR Bloomberg 1-3 Month T-Bill ETF), which saw a substantial reduction of 57.73% in shares, indicating an unwinding of cash or short-term money market exposure.
• BINC (iShares Flexible Income ETF), which experienced a significant decrease of 17.35% in shares, suggesting an adjustment to their fixed income positioning.

The sales primarily involved reducing exposure to money market instruments and one actively managed income fund during the quarter.

Other Notable Changes

Beyond large-scale transactions, several other holdings showed changes in Q2 2026:

• CRSR (Corsair Gaming Inc.) was newly added or significantly increased.
• GALT (Galectin Therapeutics Inc.), despite a subsequent reduction to zero allocation, appears to have been purchased earlier in the quarter.
• ASPI (Ampio Biosciences Inc.) showed an increase of 2.37% in shares during Q2, though its allocation remains very small at just $0.17 million.

The investor also adjusted positions in other ETFs like SPHY and SCHD, but these changes were less pronounced than the significant buys and sells highlighted above.